SCHEMBL5147078

SCHEMBL5147078

NC(=O)c1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
TP53 P04637 1/20 0.39
CREBBP Q92793 1/20 0.39
OPRM1 P35372 1/20 0.39
PARP1 P09874 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
NPC1 O15118 2/20 0.38
RORC P51449 2/20 0.36
HSD17B3 P37058 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HSP90AA1 P07900 2/20 0.35
HSP90AB1 P08238 1/20 0.34
GRM4 Q14833 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147168 0.90 PTGS1 (0.51) HDAC1HDAC6PTGS1PTGS2OPRM1
SCHEMBL4791814 0.88 PTGS1 (0.45) HDAC1HDAC6PTGS1PTGS2OPRM1
SCHEMBL14422451 0.87 PTGS1 (0.43) HDAC1HDAC6PTGS1PTGS2OPRM1
SCHEMBL5147102 0.86 HDAC1 (0.48) HDAC1HDAC6PTGS1PTGS2TP53
SCHEMBL5147126 0.86 HDAC1 (0.46) HDAC1HDAC6PTGS1PTGS2TP53
SCHEMBL5145477 0.86 HDAC1 (0.46) HDAC1HDAC6PTGS1PTGS2TP53
SCHEMBL5147074 0.86 PTGS2 (0.48) HDAC1HDAC6PTGS1PTGS2OPRM1
SCHEMBL5147135 0.85 HDAC1 (0.43) HDAC1HDAC6PTGS1PTGS2TP53
SCHEMBL4771960 0.85 CYP3A4 (0.43) HDAC1HDAC6PTGS1PTGS2TP53
SCHEMBL5147172 0.84 HDAC1 (0.44) HDAC1HDAC6PTGS1PTGS2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 HDAC1 145/4885HDAC6 204/4885PTGS1 665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.